We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+6.33%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1.33B
AUM Growth
+$253M
Cap. Flow
+$204M
Cap. Flow %
15.35%
Top 10 Hldgs %
6.81%
Holding
1,856
New
682
Increased
391
Reduced
238
Closed
544

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$11.1M
2
RTX icon
RTX Corp
RTX
+$7.48M
3
WHR icon
Whirlpool
WHR
+$7.35M
4
ITW icon
Illinois Tool Works
ITW
+$7.03M
5
ADBE icon
Adobe
ADBE
+$6.9M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.3M
2
NVDA icon
NVIDIA
NVDA
+$10.8M
3
MSFT icon
Microsoft
MSFT
+$10.7M
4
MSI icon
Motorola Solutions
MSI
+$7.95M
5
AAPL icon
Apple
AAPL
+$7.75M

Sector Composition

Rank Sector Weight
1 Financials 17.39%
2 Consumer Discretionary 14.49%
3 Industrials 14.29%
4 Technology 12.79%
5 Healthcare 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPAA icon
1251
Motorcar Parts of America
MPAA
$264M
$124K 0.01%
+15,463
New +$139K
AIP icon
1252
Arteris
AIP
$1.4B
$124K 0.01%
+16,880
New +$109K
MAMA icon
1253
Mama's Creations
MAMA
$825M
$123K 0.01%
24,648
+13,923
+130% +$65.9K
SVC
1254
Service Properties Trust
SVC
$1.08B
$123K 0.01%
+3,625
New +$134K
VIRC icon
1255
Virco
VIRC
$95M
$123K 0.01%
+11,227
New +$122K
LNKB
1256
DELISTED
LINKBANCORP
LNKB
$122K 0.01%
17,620
+6,395
+57% +$46.1K
CTMX icon
1257
CytomX Therapeutics
CTMX
$708M
$121K 0.01%
+55,595
New +$103K
PYXS icon
1258
Pyxis Oncology
PYXS
$184M
$120K 0.01%
+28,053
New +$118K
VXRT
1259
DELISTED
Vaxart
VXRT
$119K 0.01%
+91,765
New +$96.1K
NKTR icon
1260
Nektar Therapeutics
NKTR
$2.41B
$119K 0.01%
+8,504
New +$89K
AEON icon
1261
AEON Biopharma
AEON
$11.5M
$116K 0.01%
+139
New +$101K
STIM icon
1262
Neuronetics
STIM
$126M
$116K 0.01%
+24,362
New +$85.6K
KW
1263
DELISTED
Kennedy-Wilson Holdings
KW
$115K 0.01%
13,445
-1,948
-13% -$19.2K
GTHX
1264
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$115K 0.01%
26,703
+5,582
+26% +$19.5K
LZM icon
1265
Lifezone Metals
LZM
$302M
$115K 0.01%
+14,985
New +$98K
LVO icon
1266
LiveOne
LVO
$64.1M
$112K 0.01%
+5,755
New +$91.5K
ELEV
1267
DELISTED
Elevation Oncology
ELEV
$112K 0.01%
+21,805
New +$70.6K
RLMD icon
1268
Relmada Therapeutics
RLMD
$546M
$112K 0.01%
+24,016
New +$116K
LNAI
1269
Lunai Bioworks
LNAI
$10.1M
$111K 0.01%
526
+295
+128% +$79.6K
ULBI icon
1270
Ultralife
ULBI
$90.1M
$110K 0.01%
+12,500
New +$102K
BYSI icon
1271
BeyondSpring
BYSI
$48.1M
$110K 0.01%
+30,677
New +$51.6K
MNTX
1272
DELISTED
Manitex International, Inc.
MNTX
$109K 0.01%
+15,890
New +$116K
GOSS icon
1273
Gossamer Bio
GOSS
$97.5M
$107K 0.01%
+90,806
New +$100K
SCLX icon
1274
Scilex Holding
SCLX
$49.4M
$107K 0.01%
1,916
+1,175
+159% +$68.5K
AEYE icon
1275
AudioEye
AEYE
$74.7M
$106K 0.01%
+10,571
New +$69.3K

Similar funds

Y-Intercept (HK)'s Q1 2024 Portfolio in Review

As of Q1 2024, Y-Intercept (HK) held 1,856 positions worth $1.33B, up 24% from $1.07B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Y-Intercept (HK) deployed $204M of net new capital in Q1 2024, opening 682 new positions and adding to 391 existing holdings. Its largest new stake was General Motors: 287,173 shares worth $13M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Merck, an estimated $12.3M trimmed.

  • Y-Intercept (HK)'s largest Q1 2024 buy was General Motors: 287,173 shares worth $13M.
  • Y-Intercept (HK) added most to Illinois Tool Works in Q1 2024, an estimated $7.03M increase.
  • Y-Intercept (HK)'s biggest Q1 2024 reduction was Merck, cutting an estimated $12.3M.
  • Y-Intercept (HK) fully exited NVIDIA in Q1 2024, selling an estimated $10.8M.
  • Y-Intercept (HK)'s ten largest holdings make up 6.8% of its $1.33B portfolio in Q1 2024.
  • Y-Intercept (HK) opened 682 new positions and closed 544 in Q1 2024.
  • Y-Intercept (HK)'s portfolio value rose 24% quarter-over-quarter to $1.33B.

Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.